Skip to content

Observation on the clinical effect of traditional Chinese medicine Baiji in the treatment of mild to moderate ulcerative colitis with damp-heat syndrome

Observation on the clinical effect of traditional Chinese medicine Baiji in the treatment of mild to moderate ulcerative colitis with damp-heat syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000657
Enrollment
Unknown
Registered
2024-11-05
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

1:Mesalazine granules
2:Mesalazine granules and Baiji power

Sponsors

Xuzhou Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) In line with UC Western diagnostic standards and TCM large intestine damp-heat type differentiation. (2) Patients with mild to moderate activity. (3) Voluntary participants have good compliance with the observation and treatment of the researchers, and the patients and their families are informed and agree to participate in this study. (4) Age 18-65 years old.

Exclusion criteria

Exclusion criteria: (1) Patients with severe complications such as intestinal stenosis, intestinal obstruction, intestinal perforation, toxic megacolon; (2) Patients with serious heart, brain, liver, kidney, lung and other basic diseases; (3) Patients with malignant tumors, blood system diseases and serious mental diseases; (4) known to have a history of allergy to the components of this drug, food and drug allergy; (5) Pregnant and lactating women. (6) Patients who are participating in other clinical trials; (7) Other conditions that the physician considers inappropriate as a subject.

Design outcomes

Primary

MeasureTime frame
Rectal bleeding;PCR;PCT;Number of stools;IL-6;FC;

Secondary

MeasureTime frame
Routine blood test;Routine stool test;Urine routine test;

Countries

China

Contacts

Public ContactYao Tong

Xuzhou Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine

tongyao9681@163.com15062112860

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026